000 | 01857 a2200493 4500 | ||
---|---|---|---|
005 | 20250516175657.0 | ||
264 | 0 | _c20140619 | |
008 | 201406s 0 0 eng d | ||
022 | _a1879-1220 | ||
024 | 7 |
_a10.1016/j.jsbmb.2013.10.009 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGurney, Elizabeth P | |
245 | 0 | 0 |
_aThe Women's Health Initiative trial and related studies: 10 years later: a clinician's view. _h[electronic resource] |
260 |
_bThe Journal of steroid biochemistry and molecular biology _cJul 2014 |
||
300 |
_a4-11 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAtherosclerosis _xetiology |
650 | 0 | 4 |
_aBreast Neoplasms _xetiology |
650 | 0 | 4 |
_aCalcium _xadministration & dosage |
650 | 0 | 4 |
_aCognition _xdrug effects |
650 | 0 | 4 |
_aCoronary Disease _xetiology |
650 | 0 | 4 |
_aEstrogen Replacement Therapy _xadverse effects |
650 | 0 | 4 |
_aEstrogens, Conjugated (USP) _xadverse effects |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFractures, Bone _xprevention & control |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aMedroxyprogesterone Acetate _xadverse effects |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aPostmenopause _xdrug effects |
650 | 0 | 4 |
_aProgestins _xtherapeutic use |
650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
650 | 0 | 4 | _aRisk Assessment |
650 | 0 | 4 |
_aStroke _xetiology |
650 | 0 | 4 |
_aTestosterone _xadministration & dosage |
650 | 0 | 4 |
_aVenous Thromboembolism _xetiology |
650 | 0 | 4 |
_aVitamin D _xadministration & dosage |
650 | 0 | 4 | _aWomen's Health |
700 | 1 | _aNachtigall, Margaret J | |
700 | 1 | _aNachtigall, Lila E | |
700 | 1 | _aNaftolin, Frederick | |
773 | 0 |
_tThe Journal of steroid biochemistry and molecular biology _gvol. 142 _gp. 4-11 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jsbmb.2013.10.009 _zAvailable from publisher's website |
999 |
_c23214013 _d23214013 |